Test Code TESTO Testosterone, Total
Additional Codes
Cerner |
NextGen |
Testosterone, Total |
Testosterone, Total |
Methodology
Chemiluminescence Competitive immunoassay
Patient Preparation
None
Collection Instructions
Standard phlebotomy practices.
Specimen Requirements
Container |
|
||||||||||||
Stability |
|
||||||||||||
Rejection Criteria |
Gross Hemolysis Turbid Specimens |
Result Reporting and Reference Values
Reported in ng/dL
|
Low |
High |
0 to 6 Months Male |
8.0 |
642 |
6 Months to 12 Years Male |
|
46.1 |
12 to 15 Years Male |
10.4 |
717 |
15 to 19 Years Male |
117 |
782 |
Normal Male (19-49 Years) |
132 |
813 |
Normal Male (>49 Years) |
71.8 |
623 |
|
|
|
0 to 6 Months Female |
5.5 |
401 |
6 Months to 12 Years Female |
|
46.1 |
12 to 19 Years Female |
15.3 |
63.7 |
Females with normal menstrual cycles (19-150 Y) |
5.7 |
77.0 |
Reflex Testing
None
Limitations
- Ortho reports a bias with the following:
- Biotin can cause a biased result
- Bilirubin >10 mg/dL may cause a positive bias
Useful For
Testosterone is produced by the adrenals, the theca cells in the ovary and the Leydig cells in the testes. As much as 97% of circulating testosterone is bound to serum proteins such as sex hormone binding globulin (SHBG). In the male, testosterone stimulates the maturation of genitalia and secondary sexual characteristics, and its measurement is used to investigate sexual dysfunction in juveniles and adults. In female’s testosterone concentrations are much lower and an elevated concentration may indicate polycystic ovarian syndrome among other conditions. Clinical symptoms of testosterone excess in females include infertility, amenorrhea, obesity and hirsutism.